Davidson Kempner Capital Management LP Atai Life Sciences N.V. Transaction History
Davidson Kempner Capital Management LP
- $2.79 Billion
- Q1 2025
A detailed history of Davidson Kempner Capital Management LP transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Davidson Kempner Capital Management LP holds 1,413,443 shares of ATAI stock, worth $3.89 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,413,443Holding current value
$3.89 Million% of portfolio
0.07%Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
100Shares Held
23.7MCall Options Held
351KPut Options Held
170K-
Ubs Group Ag5.54MShares$15.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.29MShares$9.06 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.59MShares$7.13 Million0.42% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$3.59 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.14MShares$3.12 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $456M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...